On Thursday, Omega Healthcare Investors Inc (NYSE:OHI)’s shares dwindled -3.76%, and closed at $38.69, soon after Omega Healthcare Investors Inc (OHI) and Aviv REIT, Inc. (AVIV) declared the completion of Omega’s attainment of all of the outstanding shares of Aviv in a stock-for-stock merger, forming a combined corporation with equity market capitalization of about $7.8 billion and a total market capitalization of about $11.1 billion. The combined corporation will be the premier publicly traded real estate investment trust (REIT) focused principally on skilled nursing facilities (SNFs), with a diversified portfolio of investments counting over 900 properties located in 41 states and operated by 81 different operators.
“We believe that the combination with Aviv and the expertise and proven track records of the combined administration team firmly positions Omega to continue as the leading consolidator in the large, highly fragmented SNF industry,” said Taylor Pickett, Omega’s Chief Executive Officer.
Craig M. Bernfield, Aviv’s former Chairman and Chief Executive Officer, stated: “I am confident that our vision to substantially grow Aviv’s platform of high quality properties and operators will be implemented through the combination of these two outstanding companies, and I believe that our combined industry knowledge, experience and relationships will be the key to our future success.”
Omega Healthcare Investors, Inc. is a real estate investment firm. The firm invests in the real estate markets of United States. It invests in healthcare facilities, primarily in long-term healthcare facilities in order to create its portfolio. Omega Healthcare Investors, Inc. was founded in 1992 and is based in Maryland, United States.
At the end of Thursday’s trade, NorthStar Asset Administration Group Inc (NYSE:NSAM)’s shares dipped -3.73%, and closed at $22.69, as NorthStar Asset Administration Group Inc (NSAM), declared that it has closed the attainment of a €1.1 billion pan-European office portfolio (the “Portfolio”) that NorthStar Realty reached an contract to attain in 2014. The Portfolio is comprised of 11 Class A office properties located across gateway cities in seven of Europe’s top markets: London, UK; Paris, France; Hamburg, Germany; Milan, Italy; Brussels, Belgium; Amsterdam and Rotterdam, Netherlands; and Gothenburg, Sweden. The Portfolio is about 186,000 square meters and benefits from a well-diversified mix of market leading tenants.
NorthStar Realty financed the attainment with €530 million of seven year senior mortgages, denominated primarily in the local currencies of the respective properties, with a current weighted average interest rate of about 1.8%.
Northstar Asset Administration Group Inc. provides asset administration and other services in the United States and internationally. It also offers securitization transaction services. The corporation is based in New York, New York. Northstar Asset Administration Group Inc. (NYSE:NSAM) operates independently of NorthStar Realty Finance Corp. as of June 30, 2014.
MEI Pharma Inc (NASDAQ:MEIP), ended its Thursday’s trading session with -3.70% loss, and closed at $1.82, as MEI Pharma Inc (MEIP), declared that Daniel P. Gold, Ph.D., President and Chief Executive Officer, will present at the 14th Annual Needham Healthcare Conference on Wednesday, April 15, 2015 at 1:40 p.m. Eastern time from the Westin Grand Central Hotel in New York.
MEI Pharma, Inc., an oncology corporation, focuses on the clinical development of novel therapies for the treatment of cancer. The corporations lead drug candidate is Pracinostat, an orally accessible histone deacetylase inhibitor, which is in Phase II clinical trial for the treatment of hematologic diseases, such as myelodysplastic syndrome and acute myeloid leukemia. Its clinical development pipeline also comprises ME-344, an isoflavone-derived mitochondrial inhibitor drug candidate that is in Phase Ib trial to treat lung and ovarian cancer; and PWT143, an oral inhibitor of phosphatidylinositide 3-kinase, which is in pre-clinical stage for the treatment of cancer.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
